Cell Cycle/Checkpoint
Cell Cycle
Cells undergo a complex cycle of growth and division that is referred to as the cell cycle. The cell cycle consists of four phases, G1 (GAP 1), S (synthesis), G2 (GAP 2) and M (mitosis). DNA replication occurs during S phase. When cells stop dividing temporarily or indefinitely, they enter a quiescent state called G0.
Targets for Cell Cycle/Checkpoint
- ATM/ATR(26)
- Aurora Kinase(47)
- Cdc42(4)
- Cdc7(4)
- Chk(16)
- c-Myc(20)
- CRM1(8)
- Cyclin-Dependent Kinases(91)
- E1 enzyme(1)
- G-quadruplex(14)
- Haspin(7)
- HMTase(1)
- Kinesin(26)
- Ksp(6)
- Microtubule/Tubulin(243)
- Mps1(15)
- Mitotic(11)
- RAD51(18)
- ROCK(71)
- Rho(13)
- PERK(11)
- PLK(37)
- PTEN(8)
- Wee1(7)
- PAK(21)
- Arp2/3 Complex(8)
- Dynamin(12)
- ECM & Adhesion Molecules(40)
- Cholesterol Metabolism(3)
- Endomembrane System & Vesicular Trafficking(26)
- G1(38)
- G2/M(26)
- G2/S(10)
- Genotoxic Stress(18)
- Inositol Phosphates(18)
- Proteolysis(99)
- Cytoskeleton & Motor Proteins(53)
- Cellular Chaperones(8)
Products for Cell Cycle/Checkpoint
- Cat.No. Product Name Information
-
GC44730
proTAME
proTAME is a cell-permeable prodrug form of N-4-tosyl-L-arginine methyl ester, an inhibitor of the anaphase-promoting complex/cyclosome (APC/C), that is converted to TAME by intracellular esterases.
- GC44732 Protopine (hydrochloride) Protopine is an alkaloid found in Berberidaceae, Ranunculaceae, Rutaceae, Fumariaceae, and Papaveraceae with diverse biological activities.
- GC49914 Pt(II)-NHC Complex 2C An inducer of immunogenic cancer cell death
-
GC69776
PT-262
PT-262 is an effective ROCK inhibitor with an IC50 value of approximately 5 μM. PT-262 induces loss of mitochondrial membrane potential and increases activation of caspase-3 and cell apoptosis. PT-262 inhibits phosphorylation of ERK and CDC2 through a p53-independent pathway. PT-262 blocks cellular cytoskeleton function and cell migration. PT-262 has anti-cancer activity.
- GC44740 PtdIns-(1,2-dioctanoyl) (sodium salt) The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids.
- GC44743 PtdIns-(3)-P1 (1,2-dioctanoyl) (sodium salt) The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids.
- GC44748 PtdIns-(3,4,5)-P3 (1,2-dihexanoyl) (ammonium salt) The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids.
- GC44750 PtdIns-(3,4,5)-P3 (1,2-dipalmitoyl) (sodium salt) The phosphatidylinositol phosphates represent a small percentage of total membrane phospholipids.
- GC44753 PtdIns-(3,4,5)-P3-biotin (sodium salt) The PtdIn phosphates play an important role in the generation and transduction of intracellular signals.
- GC44759 PtdIns-(4)-P1 (1,2-dioctanoyl) (ammonium salt) The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids.
- GC52484 Purified Ganglioside Mixture (bovine) (ammonium salt) A mixture of purified bovine gangliosides
- GC14707 Purvalanol A potent, and cell-permeable CDK inhibitor
- GC16268 Purvalanol B CDK1/CDK2/CDK4 inhibitor
- GC45552 Pyrenophorol
-
GC15162
Pyridostatin
Pyridostatin is a highly selective G-quadruplex-binding small molecule that was designed to target polymorphic G-quadruplex structures regardless of sequence variability.
- GC48016 Pyridostatin (trifluoroacetate salt) Pyridostatin (RR82) TFA is a G-quadruplex DNA stabilizing agent (Kd=490 nM). Pyridostatin (trifluoroacetate salt) promotes growth arrest in human cancer cells by inducing replication- and transcription-dependent DNA damage. Pyridostatin (trifluoroacetate salt) targets the proto-oncogene Src. Pyridostatin (trifluoroacetate salt) reduced SRC protein levels and SRC-dependent cellular motility in human breast cancer cells.
- GC37043 Pyridostatin hydrochloride Pyridostatin (RR82) hydrochloride is a G-quadruplex DNA stabilizing agent (Kd=490 nM). Pyridostatin hydrochloride promotes growth arrest in human cancer cells by inducing replication- and transcription-dependent DNA damage. Pyridostatin hydrochloride targets the proto-oncogene Src. Pyridostatin hydrochloride reduced SRC protein levels and SRC-dependent cellular motility in human breast cancer cells.
- GC17801 PYZD-4409 E1 enzyme inhibitor
- GC52057 QN523 An anticancer agent
- GC45903 Quazinone A PDE3 inhibitor
- GC48019 Quercetin (hydrate) A flavonoid with diverse biological activities
- GC46210 Quinacrine mustard (hydrochloride) Quinacrine mustard (hydrochloride) is a fluorochrome.
- GC44800 Quininib A CysLT1 and CysLT2 receptor antagonist
- GC17400 R547 CDK1/2/4 inhibitor,ATP-competitive
- GC49771 rac-Hesperetin-d3 An internal standard for the quantification of hesperetin
- GC49108 Racecadotril-d5 An internal standard for the quantification of racecadotril
- GC19306 RAD51 Inhibitor B02 RAD51 Inhibitor B02 (B02) is an inhibitor of human RAD51 with an IC50 of 27.4 uM.
- GC63165 RAD51-IN-1 RAD51-IN-1, a derivative of ?B02, is a potent inhibitor of RAD51. RAD51-IN-1 can be used for cancer research.
- GC65383 RAD51-IN-2 RAD51-IN-2 (compound example 67A) is a RAD51 inhibitor extracted from patent WO2019/051465A1.
- GC68416 RAD51-IN-3
- GC67888 RAD51-IN-5
- GC52054 Ranitidine S-oxide Ranitidine S-oxide is the metabolite of Ranitidine.
- GC52196 RGD Peptide RGD Peptide acts as an inhibitor of integrin-ligand interactions and plays an important role in cell adhesion, migration, growth, and differentiation.
-
GC45798
Rhein-13C4
An internal standard for the quantification of rhein
- GC33310 Rho-Kinase-IN-1 Rho-Kinase-IN-1 is a Rho kinase (ROCK) inhibitor (Ki values of 30.5 and 3.9 nM for ROCK1 and ROCK2, respectively) extracted from US20090325960A1, compound 1.008.
- GC66050 Rho-Kinase-IN-2 Rho-Kinase-IN-2 (Compound 23) is an orally active, selective, and central nervous system (CNS)-penetrant Rho Kinase (ROCK) inhibitor (ROCK2 IC50=3 nM). Rho-Kinase-IN-2 can be used in Huntington's research.
- GC44829 Rhod-5N (potassium salt) Rhod-5N is a low affinity fluorescent calcium probe (Kd = 320 μM).
- GC18140 RI-1 A RAD51 inhibitor
- GC12752 RI-2 Optimized reversible RAD51 inhibitor
-
GC12415
Rigosertib
PI3K/PLK1 inhibitor
- GC14358 Rigosertib (ON-01910,Estybon) Plk1 inhibitor
-
GC13580
Rigosertib sodium
Non-ATP-competitive inhibitor of PLK1
- GC37534 Ripasudil free base Ripasudil free base (K-115 free base) is a specific inhibitor of ROCK, with IC50s of 19 and 51 nM for ROCK2 and ROCK1, respectively.
- GC48401 Risuteganib (trifluoroacetate salt) An anti-integrin peptide
- GC44846 RK-682 (calcium salt) Protein tyrosine phosphatases (PTPs) remove phosphate from tyrosine residues of cellular proteins.
- GC50092 RKI 1447 dihydrochloride Potent and selective ROCK inhibitor; antitumor
- GC44847 RKI-1313 A ROCK1 and ROCK2 inhibitor
- GC15437 RKI-1447 A ROCK1 and ROCK2 inhibitor
- GC12348 Ro 3306 An ATP-competitive, potent CDK1 inhibitor
- GC13903 Ro3280 PLK1 inhibitor,potent and highly selective
- GC37551 ROCK inhibitor-2 ROCK inhibitor-2 is a selective dual ROCK1 and ROCK2 inhibitor with IC50s of 17 nM and 2 nM, respectively.
- GC31952 ROCK-IN-1 ROCK-IN-1 is a potent inhibitor of ROCK, with an IC50 of 1.2 nM for ROCK2.
- GC66338 ROCK1-IN-1 ROCK1-IN-1 is a ROCK1 inhibitor with a Ki value of 540 nM. ROCK1-IN-1 can be used for the research of hypertension, glaucoma and erectile dysfunction.
- GC31883 ROCK2-IN-2 ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC50 of <1 μM.
- GC33169 Rosabulin (STA 5312) Rosabulin (STA 5312) (STA 5312) is a potent and orally active microtubule inhibitor that inhibits microtubule assembly. Rosabulin (STA 5312) has broad-spectrum anti-tumor activity.
- GC11401 Roscovitine (Seliciclib,CYC202) Roscovitine (Seliciclib,CYC202) (Roscovitine) is an orally bioavailable and selective CDKs inhibitor with IC50s of 0.2 μM, 0.65 μM, and 0.7 μM for CDK5, Cdc2, and CDK2, respectively.
- GC64278 RP-3500 RP-3500 (ATR inhibitor 4) is an orally active, selective ATR kinase inhibitor (ATRi) with an IC50 of 1.00 nM in biochemical assays. RP-3500 shows 30-fold selectivity for ATR over mTOR (IC50=120 nM) and >2,000-fold selectivity over ATM, DNA-PK, and PI3Kα kinases. RP-3500 has potent antitumor activity.
- GC16265 RS-1 RAD51 activator
- GC18847 RSM-932A RSM-932A is a ChoKα inhibitor
- GC17150 Ryuvidine SETD8 protein lysine methyltransferase (PKMT) inhibitor
- GC49532 S-(1,2-Dichlorovinyl)-Cysteine (hydrochloride) A nephrotoxin and metabolite of trichloroethylene
- GC46224 S-Phenylcysteine An adduct
- GC18852 S14161 D-Cyclins regulate the cell cycle by acting in a complex with cyclin dependent kinases (CDKs) to promote phosphorylation of the retinoblastoma protein and initiate cellular progression from the G1 to the S phase.
- GC38945 S516 S516 (Compound 22) is an active metabolite of CKD-516 and a potent tubulin polymerization inhibitor with an IC50 of 4.29 μM. S516 has marked antitumor activity.
- GC49093 Safflower Red A red pigment with diverse biological activities
- GC38845 sAJM589 sAJM589 is a Myc inhibitor which potently disrupts the Myc-Max heterodimer with an IC50 of 1.8 μM.
- GC13759 SAR407899 ATP-competitive ROCK inhibitor
- GC16289 SAR407899 hydrochloride ATP-competitive ROCK inhibitor
- GC46218 Satratoxin G A macrocyclic trichothecene mycotoxin
- GC46219 Satratoxin H A trichothecene mycotoxin
- GC11022 SB 218078 checkpoint kinase 1 (Chk1) inhibitor
- GC15170 SB 772077B dihydrochloride Rho-kinase (ROCK) inhibitor
- GC66437 SB-216 SB-216 is a potent tubulin polymerization inhibitor. SB-216 shows strong antiproliferative potency in a panel of human cancer cell lines, including melanoma, lung cancer, and breast cancer. SB-216 can be used for cancer research.
- GC12064 SB1317 A multi-kinase inhibitor
- GC14600 SB743921 SB743921 is a potent inhibitor of the mitotic kinesin KSP (Eg5), with a Ki of 0.1 nM.
- GC14644 SBE 13 HCl SBE 13 HCl is a potent and selective Plk1 inhibitor, with an IC50 of 200 pM; SBE 13 HCl poorly inhibits Plk2 (IC50>66μM) or Plk3 (IC50=875nM).
- GC37601 SBE13 SBE13 is a potent and selective Plk1 inhibitor, with an IC50 of 200 pM; SBE13 poorly inhibits Plk2 (IC50>66?μM) or Plk3 (IC50=875?nM).
- GC37606 SCH-1473759 hydrochloride SCH-1473759 hydrochloride is an aurora inhibitor with IC50s of 4 and 13 nM for aurora A and B, respectively.
- GC17792 SCH900776 S-isomer
- GN10091 Schaftoside
- GC49674 Schizandrin Schizandrin (Schizandrin), a dibenzocyclooctadiene lignan, is isolated from the fruit of Schisandra chinensis Baill.
- GC39798 Scoulerine Scoulerine ((-)-Scoulerine), an isoquinoline alkaloid, is a potent antimitotic compound. Scoulerine is also an inhibitor of BACE1 (?-site amyloid precursor protein cleaving enzyme 1). Scoulerine inhibits proliferation, arrests cell cycle, and induces apoptosis in cancer cells.
- GC49723 SenTraGor™ Cell Senescence Reagent A cellular senescence detection reagent
- GC48076 Sesquicillin A A fungal metabolite
- GC10019 SF1670 PTEN inhibitor, potent and specific
- GC49713 SIKVAV (acetate) A laminin α1-derived peptide
- GC49002 Sinigrin (hydrate) A glucosinolate with diverse biological activities
- GC64539 SKLB-197 SKLB-197 showed an IC50 value of 0.013 μM against ATR but very weak or no activity against other 402 protein kinases. It displayed potent antitumor activity against ATM-deficent tumors both in vitro and in vivo.
- GC12827 SLx-2119 A ROCK2 inhibitor
- GC11396 SNS-032 (BMS-387032) SNS-032 (BMS-387032) (BMS-387032) is a potent and selective inhibitor ofCDK2, CDK7, and CDK9 withIC50sof 38 nM, 62 nM and 4 nM, respectively. SNS-032 (BMS-387032) has antitumor effect.
- GC25940 SNS-314 SNS-314 is a potent and selective inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 9 nM, 31 nM, and 3 nM, respectively. It is less potent to Trk A/B, Flt4, Fms, Axl, c-Raf and DDR2. Phase 1.
- GC32935 Soblidotin (Auristatin PE) Soblidotin (Auristatin PE) (Auristatin PE) is a novel synthetic Dolastatin 10 derivative and inhibitor of tubulin polymerization.
- GC48084 Sodium 4-Phenylbutyrate-d11 Phenylbutyrate-d11 (sodium) is deuterium labeled Sodium 4-phenylbutyrate. Sodium 4-phenylbutyrate (4-PBA sodium) is an inhibitor of HDAC and endoplasmic reticulum (ER) stress, used in cancer and infection research.
- GC65887 SOP1812 SOP1812 is a naphthalene diimide (ND) derivative with anti-tumor activity. SOP1812 binds to quadruplex arrangements (G4s), and down-regulates several cancer gene pathways. SOP1812 shows great affinity to hTERT G4 and HuTel21 G4 with KD values of 4.9 and 28.4 nM, respectively. SOP1812 can be used for the research of cancer.
- GC63351 Sovesudil Sovesudil (PHP-201) is a potent, ATP-competitive, locally acting Rho kinase (ROCK) inhibitor with IC50s of 3.7 and 2.3 nM for ROCK-I and ROCK-II, respectively.
- GC63716 Sovesudil hydrochloride Sovesudil (PHP-201) hydrochloride is a potent, ATP-competitive, locally acting Rho kinase (ROCK) inhibitor with IC50s of 3.7 and 2.3 nM for ROCK-I and ROCK-II, respectively.
- GC64019 Sovilnesib Sovilnesib (AMG 650) is a kinesin-like protein KIF18A inhibitor (WO2020132648). Sovilnesib can be used for the research of cancer.
- GC48092 Spinosad A naturally-occurring insecticide
- GC41258 Spiroxamine Spiroxamine is a tertiary amine fungicide and an inhibitor of δ14 reductase/δ8→δ7 isomerase.
- GC44946 Sporidesmolide III Sporidesmolide III is a cyclodepsipeptide originally isolated from P.